Allogenic Stem Cell Transplantation for Children, Adolescents and Young Adults With Relapsed or Refractory AML; Multi Center Therapy Concept
Target variables:
- Treatment response
- Event Free Survival
- Leukemia Free Survival
- Graft Versus Host Disease
- Regimen related toxicity
Interventional
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
To evaluate whether stem cell transplantation (SCT) from a matched sibling donor (MSD) is equivalent to a matched unrelated donor (MUD) in second complete remission (CR2).
day 100
Yes
Martin Sauer, Prof. Dr.
Principal Investigator
Hannover Medical School
Germany: Paul-Ehrlich-Institut
AML SCT-BFM 2007
NCT00606723
April 2010
July 2019
Name | Location |
---|